US equities
|
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Alec Stranahan
Recent news which mentions Alec Stranahan
Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
November 19, 2024
Tickers
LLY
Tags
pharmacueticals
weight/loss drugs
Top Stories
From
Benzinga
Why This Novavax Analyst Remains Bearish After COVID Vaccine Panel Vote
June 08, 2022
Tickers
NVAX
Tags
Health Care
Reiteration
Analyst Color
From
Benzinga
5 Small-Cap S&P Stocks To Buy With The Most Upside
May 26, 2022
Tickers
AXL
CYH
RGNX
TGI
Tags
Benzinga
Ronald Epstein
Long Ideas
From
Benzinga
Novavax Has Limited Pipeline Upside, Says BofA Analyst: What's Next?
May 20, 2022
Tickers
NVAX
Tags
Initiation
Market News
BofA Securities
From
Benzinga